APA (7th ed.) Citation

Rothan, H., Amini, E., Faraj, F., Golpich, M., Teoh, T., Gholami, K., & Yusof, R. (2017). NMDA receptor antagonism with novel indolyl, 2-(1,1-Dimethyl-1,3-dihydro-benzo[e]indol-2-ylidene)-malonaldehyde, reduces seizures duration in a rat model of epilepsy. Nature Publishing Group.

Chicago Style (17th ed.) Citation

Rothan, H.A, E. Amini, F.L Faraj, M. Golpich, T.C Teoh, K. Gholami, and R. Yusof. NMDA Receptor Antagonism with Novel Indolyl, 2-(1,1-Dimethyl-1,3-dihydro-benzo[e]indol-2-ylidene)-malonaldehyde, Reduces Seizures Duration in a Rat Model of Epilepsy. Nature Publishing Group, 2017.

MLA (9th ed.) Citation

Rothan, H.A, et al. NMDA Receptor Antagonism with Novel Indolyl, 2-(1,1-Dimethyl-1,3-dihydro-benzo[e]indol-2-ylidene)-malonaldehyde, Reduces Seizures Duration in a Rat Model of Epilepsy. Nature Publishing Group, 2017.